nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Temsirolimus—kidney cancer	0.113	0.169	CbGbCtD
Hydrocodone—CYP3A4—Everolimus—kidney cancer	0.107	0.159	CbGbCtD
Hydrocodone—CYP3A4—Temsirolimus—kidney cancer	0.0721	0.108	CbGbCtD
Hydrocodone—CYP2D6—Pazopanib—kidney cancer	0.0595	0.0889	CbGbCtD
Hydrocodone—CYP2D6—Erlotinib—kidney cancer	0.0425	0.0635	CbGbCtD
Hydrocodone—CYP3A4—Pazopanib—kidney cancer	0.0378	0.0565	CbGbCtD
Hydrocodone—CYP2D6—Sorafenib—kidney cancer	0.0345	0.0516	CbGbCtD
Hydrocodone—CYP2D6—Vinblastine—kidney cancer	0.0341	0.0509	CbGbCtD
Hydrocodone—CYP3A4—Erlotinib—kidney cancer	0.027	0.0404	CbGbCtD
Hydrocodone—CYP3A4—Paclitaxel—kidney cancer	0.0247	0.0369	CbGbCtD
Hydrocodone—CYP3A4—Sorafenib—kidney cancer	0.022	0.0328	CbGbCtD
Hydrocodone—CYP3A4—Vinblastine—kidney cancer	0.0217	0.0324	CbGbCtD
Hydrocodone—CYP3A4—Vincristine—kidney cancer	0.0213	0.0319	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—kidney cancer	0.021	0.0313	CbGbCtD
Hydrocodone—CYP3A4—Sunitinib—kidney cancer	0.0178	0.0266	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—kidney cancer	0.0133	0.0199	CbGbCtD
Hydrocodone—Galantamine—ACHE—kidney cancer	0.00159	0.329	CrCbGaD
Hydrocodone—Galantamine—BCHE—kidney cancer	0.000938	0.193	CrCbGaD
Hydrocodone—Hydromorphone—PTGS1—kidney cancer	0.000792	0.163	CrCbGaD
Hydrocodone—Naltrexone—ABCB1—kidney cancer	0.000532	0.11	CrCbGaD
Hydrocodone—Insomnia—Sunitinib—kidney cancer	0.000493	0.00151	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000491	0.00151	CcSEcCtD
Hydrocodone—Nausea—Pazopanib—kidney cancer	0.000491	0.00151	CcSEcCtD
Hydrocodone—Paraesthesia—Sunitinib—kidney cancer	0.000489	0.0015	CcSEcCtD
Hydrocodone—Convulsion—Vincristine—kidney cancer	0.000489	0.0015	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000489	0.0015	CcSEcCtD
Hydrocodone—Fatigue—Sorafenib—kidney cancer	0.000488	0.0015	CcSEcCtD
Hydrocodone—Dyspnoea—Sunitinib—kidney cancer	0.000486	0.00149	CcSEcCtD
Hydrocodone—Constipation—Sorafenib—kidney cancer	0.000484	0.00149	CcSEcCtD
Hydrocodone—Hypersensitivity—Vinblastine—kidney cancer	0.000482	0.00148	CcSEcCtD
Hydrocodone—Myalgia—Vincristine—kidney cancer	0.000481	0.00148	CcSEcCtD
Hydrocodone—Hypersensitivity—Everolimus—kidney cancer	0.000481	0.00147	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00047	0.00144	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00047	0.00144	CcSEcCtD
Hydrocodone—Asthenia—Vinblastine—kidney cancer	0.00047	0.00144	CcSEcCtD
Hydrocodone—Fatigue—Sunitinib—kidney cancer	0.00047	0.00144	CcSEcCtD
Hydrocodone—Asthenia—Everolimus—kidney cancer	0.000468	0.00144	CcSEcCtD
Hydrocodone—Cough—Gemcitabine—kidney cancer	0.000467	0.00143	CcSEcCtD
Hydrocodone—Angiopathy—Paclitaxel—kidney cancer	0.000467	0.00143	CcSEcCtD
Hydrocodone—Constipation—Sunitinib—kidney cancer	0.000466	0.00143	CcSEcCtD
Hydrocodone—Mediastinal disorder—Paclitaxel—kidney cancer	0.000464	0.00142	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000463	0.00142	CcSEcCtD
Hydrocodone—Pruritus—Everolimus—kidney cancer	0.000461	0.00142	CcSEcCtD
Hydrocodone—Urinary tract infection—Capecitabine—kidney cancer	0.000458	0.0014	CcSEcCtD
Hydrocodone—Arthralgia—Gemcitabine—kidney cancer	0.000456	0.0014	CcSEcCtD
Hydrocodone—Myalgia—Gemcitabine—kidney cancer	0.000456	0.0014	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000453	0.00139	CcSEcCtD
Hydrocodone—Nervous system disorder—Vincristine—kidney cancer	0.000452	0.00139	CcSEcCtD
Hydrocodone—Asthenia—Erlotinib—kidney cancer	0.000452	0.00139	CcSEcCtD
Hydrocodone—Mental disorder—Paclitaxel—kidney cancer	0.000451	0.00139	CcSEcCtD
Hydrocodone—Thrombocytopenia—Vincristine—kidney cancer	0.000451	0.00138	CcSEcCtD
Hydrocodone—Malnutrition—Paclitaxel—kidney cancer	0.000448	0.00138	CcSEcCtD
Hydrocodone—Abdominal pain—Sorafenib—kidney cancer	0.000448	0.00137	CcSEcCtD
Hydrocodone—Body temperature increased—Sorafenib—kidney cancer	0.000448	0.00137	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000445	0.00137	CcSEcCtD
Hydrocodone—Hyperhidrosis—Vincristine—kidney cancer	0.000445	0.00137	CcSEcCtD
Hydrocodone—Pruritus—Erlotinib—kidney cancer	0.000445	0.00137	CcSEcCtD
Hydrocodone—Fatigue—Dactinomycin—kidney cancer	0.000445	0.00136	CcSEcCtD
Hydrocodone—Agranulocytosis—Capecitabine—kidney cancer	0.000439	0.00135	CcSEcCtD
Hydrocodone—Back pain—Paclitaxel—kidney cancer	0.000434	0.00133	CcSEcCtD
Hydrocodone—Dizziness—Vinblastine—kidney cancer	0.000433	0.00133	CcSEcCtD
Hydrocodone—Dizziness—Everolimus—kidney cancer	0.000431	0.00132	CcSEcCtD
Hydrocodone—Muscle spasms—Paclitaxel—kidney cancer	0.000431	0.00132	CcSEcCtD
Hydrocodone—Abdominal pain—Sunitinib—kidney cancer	0.000431	0.00132	CcSEcCtD
Hydrocodone—Body temperature increased—Sunitinib—kidney cancer	0.000431	0.00132	CcSEcCtD
Hydrocodone—Hypotension—Vincristine—kidney cancer	0.000431	0.00132	CcSEcCtD
Hydrocodone—Nervous system disorder—Gemcitabine—kidney cancer	0.000429	0.00132	CcSEcCtD
Hydrocodone—Thrombocytopenia—Gemcitabine—kidney cancer	0.000428	0.00131	CcSEcCtD
Hydrocodone—Skin disorder—Gemcitabine—kidney cancer	0.000425	0.0013	CcSEcCtD
Hydrocodone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000423	0.0013	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000422	0.00129	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—kidney cancer	0.000421	0.00129	CcSEcCtD
Hydrocodone—Tremor—Paclitaxel—kidney cancer	0.00042	0.00129	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00042	0.00129	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—kidney cancer	0.000417	0.00128	CcSEcCtD
Hydrocodone—Hypersensitivity—Sorafenib—kidney cancer	0.000417	0.00128	CcSEcCtD
Hydrocodone—Insomnia—Vincristine—kidney cancer	0.000417	0.00128	CcSEcCtD
Hydrocodone—Oedema peripheral—Capecitabine—kidney cancer	0.000416	0.00128	CcSEcCtD
Hydrocodone—Vomiting—Vinblastine—kidney cancer	0.000416	0.00128	CcSEcCtD
Hydrocodone—Dizziness—Erlotinib—kidney cancer	0.000416	0.00128	CcSEcCtD
Hydrocodone—Connective tissue disorder—Capecitabine—kidney cancer	0.000415	0.00127	CcSEcCtD
Hydrocodone—Vomiting—Everolimus—kidney cancer	0.000415	0.00127	CcSEcCtD
Hydrocodone—Paraesthesia—Vincristine—kidney cancer	0.000414	0.00127	CcSEcCtD
Hydrocodone—Rash—Everolimus—kidney cancer	0.000411	0.00126	CcSEcCtD
Hydrocodone—Dermatitis—Everolimus—kidney cancer	0.000411	0.00126	CcSEcCtD
Hydrocodone—Headache—Vinblastine—kidney cancer	0.00041	0.00126	CcSEcCtD
Hydrocodone—Headache—Everolimus—kidney cancer	0.000409	0.00125	CcSEcCtD
Hydrocodone—Hypotension—Gemcitabine—kidney cancer	0.000408	0.00125	CcSEcCtD
Hydrocodone—Body temperature increased—Dactinomycin—kidney cancer	0.000408	0.00125	CcSEcCtD
Hydrocodone—Abdominal pain—Dactinomycin—kidney cancer	0.000408	0.00125	CcSEcCtD
Hydrocodone—Asthenia—Sorafenib—kidney cancer	0.000406	0.00125	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—kidney cancer	0.000402	0.00123	CcSEcCtD
Hydrocodone—Hypersensitivity—Sunitinib—kidney cancer	0.000401	0.00123	CcSEcCtD
Hydrocodone—Pruritus—Sorafenib—kidney cancer	0.000401	0.00123	CcSEcCtD
Hydrocodone—Vomiting—Erlotinib—kidney cancer	0.0004	0.00123	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000398	0.00122	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000398	0.00122	CcSEcCtD
Hydrocodone—Fatigue—Vincristine—kidney cancer	0.000397	0.00122	CcSEcCtD
Hydrocodone—Rash—Erlotinib—kidney cancer	0.000397	0.00122	CcSEcCtD
Hydrocodone—Dermatitis—Erlotinib—kidney cancer	0.000396	0.00122	CcSEcCtD
Hydrocodone—Insomnia—Gemcitabine—kidney cancer	0.000395	0.00121	CcSEcCtD
Hydrocodone—Headache—Erlotinib—kidney cancer	0.000394	0.00121	CcSEcCtD
Hydrocodone—Constipation—Vincristine—kidney cancer	0.000394	0.00121	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—kidney cancer	0.000394	0.00121	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—kidney cancer	0.000394	0.00121	CcSEcCtD
Hydrocodone—Paraesthesia—Gemcitabine—kidney cancer	0.000393	0.0012	CcSEcCtD
Hydrocodone—Cough—Paclitaxel—kidney cancer	0.000391	0.0012	CcSEcCtD
Hydrocodone—Asthenia—Sunitinib—kidney cancer	0.000391	0.0012	CcSEcCtD
Hydrocodone—Dyspnoea—Gemcitabine—kidney cancer	0.00039	0.0012	CcSEcCtD
Hydrocodone—Nausea—Vinblastine—kidney cancer	0.000389	0.00119	CcSEcCtD
Hydrocodone—Somnolence—Gemcitabine—kidney cancer	0.000389	0.00119	CcSEcCtD
Hydrocodone—Convulsion—Paclitaxel—kidney cancer	0.000389	0.00119	CcSEcCtD
Hydrocodone—Naloxone—ABCB1—kidney cancer	0.000388	0.08	CrCbGaD
Hydrocodone—Migraine—Doxorubicin—kidney cancer	0.000388	0.00119	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—kidney cancer	0.000388	0.00119	CcSEcCtD
Hydrocodone—Nausea—Everolimus—kidney cancer	0.000387	0.00119	CcSEcCtD
Hydrocodone—Pruritus—Sunitinib—kidney cancer	0.000385	0.00118	CcSEcCtD
Hydrocodone—Angiopathy—Capecitabine—kidney cancer	0.000384	0.00118	CcSEcCtD
Hydrocodone—Myalgia—Paclitaxel—kidney cancer	0.000382	0.00117	CcSEcCtD
Hydrocodone—Arthralgia—Paclitaxel—kidney cancer	0.000382	0.00117	CcSEcCtD
Hydrocodone—Mediastinal disorder—Capecitabine—kidney cancer	0.000381	0.00117	CcSEcCtD
Hydrocodone—Anxiety—Paclitaxel—kidney cancer	0.00038	0.00117	CcSEcCtD
Hydrocodone—Hypersensitivity—Dactinomycin—kidney cancer	0.00038	0.00117	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000379	0.00116	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000377	0.00116	CcSEcCtD
Hydrocodone—Fatigue—Gemcitabine—kidney cancer	0.000377	0.00116	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Vincristine—kidney cancer	0.000377	0.00116	CcSEcCtD
Hydrocodone—Dizziness—Sorafenib—kidney cancer	0.000374	0.00115	CcSEcCtD
Hydrocodone—Constipation—Gemcitabine—kidney cancer	0.000374	0.00115	CcSEcCtD
Hydrocodone—Nausea—Erlotinib—kidney cancer	0.000374	0.00115	CcSEcCtD
Hydrocodone—Dry mouth—Paclitaxel—kidney cancer	0.000373	0.00115	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—kidney cancer	0.000373	0.00115	CcSEcCtD
Hydrocodone—Mental disorder—Capecitabine—kidney cancer	0.00037	0.00114	CcSEcCtD
Hydrocodone—Asthenia—Dactinomycin—kidney cancer	0.00037	0.00114	CcSEcCtD
Hydrocodone—Malnutrition—Capecitabine—kidney cancer	0.000368	0.00113	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—kidney cancer	0.000366	0.00112	CcSEcCtD
Hydrocodone—Abdominal pain—Vincristine—kidney cancer	0.000364	0.00112	CcSEcCtD
Hydrocodone—Body temperature increased—Vincristine—kidney cancer	0.000364	0.00112	CcSEcCtD
Hydrocodone—Dizziness—Sunitinib—kidney cancer	0.00036	0.00111	CcSEcCtD
Hydrocodone—Vomiting—Sorafenib—kidney cancer	0.00036	0.0011	CcSEcCtD
Hydrocodone—Nervous system disorder—Paclitaxel—kidney cancer	0.000359	0.0011	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—kidney cancer	0.000358	0.0011	CcSEcCtD
Hydrocodone—Thrombocytopenia—Paclitaxel—kidney cancer	0.000358	0.0011	CcSEcCtD
Hydrocodone—Rash—Sorafenib—kidney cancer	0.000357	0.0011	CcSEcCtD
Hydrocodone—Dermatitis—Sorafenib—kidney cancer	0.000357	0.00109	CcSEcCtD
Hydrocodone—Back pain—Capecitabine—kidney cancer	0.000356	0.00109	CcSEcCtD
Hydrocodone—Skin disorder—Paclitaxel—kidney cancer	0.000355	0.00109	CcSEcCtD
Hydrocodone—Headache—Sorafenib—kidney cancer	0.000355	0.00109	CcSEcCtD
Hydrocodone—Muscle spasms—Capecitabine—kidney cancer	0.000354	0.00109	CcSEcCtD
Hydrocodone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000354	0.00109	CcSEcCtD
Hydrocodone—Vomiting—Sunitinib—kidney cancer	0.000346	0.00106	CcSEcCtD
Hydrocodone—Body temperature increased—Gemcitabine—kidney cancer	0.000346	0.00106	CcSEcCtD
Hydrocodone—Tremor—Capecitabine—kidney cancer	0.000345	0.00106	CcSEcCtD
Hydrocodone—Rash—Sunitinib—kidney cancer	0.000343	0.00105	CcSEcCtD
Hydrocodone—Dermatitis—Sunitinib—kidney cancer	0.000343	0.00105	CcSEcCtD
Hydrocodone—Hypotension—Paclitaxel—kidney cancer	0.000342	0.00105	CcSEcCtD
Hydrocodone—Headache—Sunitinib—kidney cancer	0.000341	0.00105	CcSEcCtD
Hydrocodone—Hypersensitivity—Vincristine—kidney cancer	0.000339	0.00104	CcSEcCtD
Hydrocodone—Nausea—Sorafenib—kidney cancer	0.000336	0.00103	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000333	0.00102	CcSEcCtD
Hydrocodone—Insomnia—Paclitaxel—kidney cancer	0.000331	0.00102	CcSEcCtD
Hydrocodone—Asthenia—Vincristine—kidney cancer	0.000331	0.00101	CcSEcCtD
Hydrocodone—Paraesthesia—Paclitaxel—kidney cancer	0.000329	0.00101	CcSEcCtD
Hydrocodone—Vomiting—Dactinomycin—kidney cancer	0.000328	0.00101	CcSEcCtD
Hydrocodone—Morphine—ABCB1—kidney cancer	0.000327	0.0676	CrCbGaD
Hydrocodone—Dyspnoea—Paclitaxel—kidney cancer	0.000326	0.001	CcSEcCtD
Hydrocodone—Somnolence—Paclitaxel—kidney cancer	0.000325	0.000999	CcSEcCtD
Hydrocodone—Rash—Dactinomycin—kidney cancer	0.000325	0.000998	CcSEcCtD
Hydrocodone—Nausea—Sunitinib—kidney cancer	0.000324	0.000993	CcSEcCtD
Hydrocodone—Cough—Capecitabine—kidney cancer	0.000321	0.000986	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000316	0.000971	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000316	0.00097	CcSEcCtD
Hydrocodone—Fatigue—Paclitaxel—kidney cancer	0.000316	0.000968	CcSEcCtD
Hydrocodone—Asthenia—Gemcitabine—kidney cancer	0.000314	0.000963	CcSEcCtD
Hydrocodone—Arthralgia—Capecitabine—kidney cancer	0.000313	0.000962	CcSEcCtD
Hydrocodone—Myalgia—Capecitabine—kidney cancer	0.000313	0.000962	CcSEcCtD
Hydrocodone—Constipation—Paclitaxel—kidney cancer	0.000313	0.000961	CcSEcCtD
Hydrocodone—Anxiety—Capecitabine—kidney cancer	0.000312	0.000958	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000311	0.000955	CcSEcCtD
Hydrocodone—Pruritus—Gemcitabine—kidney cancer	0.000309	0.000949	CcSEcCtD
Hydrocodone—Dry mouth—Capecitabine—kidney cancer	0.000306	0.00094	CcSEcCtD
Hydrocodone—Nausea—Dactinomycin—kidney cancer	0.000306	0.00094	CcSEcCtD
Hydrocodone—Dizziness—Vincristine—kidney cancer	0.000305	0.000935	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—kidney cancer	0.000304	0.000932	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000299	0.000918	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—kidney cancer	0.000295	0.000906	CcSEcCtD
Hydrocodone—Nervous system disorder—Capecitabine—kidney cancer	0.000295	0.000904	CcSEcCtD
Hydrocodone—Thrombocytopenia—Capecitabine—kidney cancer	0.000294	0.000903	CcSEcCtD
Hydrocodone—Vomiting—Vincristine—kidney cancer	0.000293	0.000899	CcSEcCtD
Hydrocodone—Skin disorder—Capecitabine—kidney cancer	0.000292	0.000895	CcSEcCtD
Hydrocodone—Rash—Vincristine—kidney cancer	0.000291	0.000892	CcSEcCtD
Hydrocodone—Hyperhidrosis—Capecitabine—kidney cancer	0.00029	0.000891	CcSEcCtD
Hydrocodone—Dermatitis—Vincristine—kidney cancer	0.00029	0.000891	CcSEcCtD
Hydrocodone—Abdominal pain—Paclitaxel—kidney cancer	0.000289	0.000888	CcSEcCtD
Hydrocodone—Body temperature increased—Paclitaxel—kidney cancer	0.000289	0.000888	CcSEcCtD
Hydrocodone—Headache—Vincristine—kidney cancer	0.000289	0.000886	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—kidney cancer	0.000283	0.000869	CcSEcCtD
Hydrocodone—Hypotension—Capecitabine—kidney cancer	0.000281	0.000861	CcSEcCtD
Hydrocodone—Vomiting—Gemcitabine—kidney cancer	0.000278	0.000853	CcSEcCtD
Hydrocodone—Rash—Gemcitabine—kidney cancer	0.000276	0.000846	CcSEcCtD
Hydrocodone—Dermatitis—Gemcitabine—kidney cancer	0.000275	0.000845	CcSEcCtD
Hydrocodone—Dextromethorphan—ABCB1—kidney cancer	0.000275	0.0567	CrCbGaD
Hydrocodone—Headache—Gemcitabine—kidney cancer	0.000274	0.00084	CcSEcCtD
Hydrocodone—Nausea—Vincristine—kidney cancer	0.000274	0.00084	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000274	0.00084	CcSEcCtD
Hydrocodone—Insomnia—Capecitabine—kidney cancer	0.000272	0.000834	CcSEcCtD
Hydrocodone—Paraesthesia—Capecitabine—kidney cancer	0.00027	0.000828	CcSEcCtD
Hydrocodone—Hypersensitivity—Paclitaxel—kidney cancer	0.00027	0.000828	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—kidney cancer	0.000268	0.000824	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—kidney cancer	0.000268	0.000822	CcSEcCtD
Hydrocodone—Dyspnoea—Capecitabine—kidney cancer	0.000268	0.000822	CcSEcCtD
Hydrocodone—Asthenia—Paclitaxel—kidney cancer	0.000263	0.000806	CcSEcCtD
Hydrocodone—Nausea—Gemcitabine—kidney cancer	0.00026	0.000797	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000259	0.000796	CcSEcCtD
Hydrocodone—Fatigue—Capecitabine—kidney cancer	0.000259	0.000795	CcSEcCtD
Hydrocodone—Pruritus—Paclitaxel—kidney cancer	0.000259	0.000795	CcSEcCtD
Hydrocodone—Constipation—Capecitabine—kidney cancer	0.000257	0.000788	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—kidney cancer	0.000247	0.000759	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000246	0.000754	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—kidney cancer	0.000246	0.000754	CcSEcCtD
Hydrocodone—Dizziness—Paclitaxel—kidney cancer	0.000242	0.000743	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—kidney cancer	0.000239	0.000733	CcSEcCtD
Hydrocodone—Abdominal pain—Capecitabine—kidney cancer	0.000237	0.000729	CcSEcCtD
Hydrocodone—Body temperature increased—Capecitabine—kidney cancer	0.000237	0.000729	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—kidney cancer	0.000237	0.000728	CcSEcCtD
Hydrocodone—Vomiting—Paclitaxel—kidney cancer	0.000233	0.000714	CcSEcCtD
Hydrocodone—Rash—Paclitaxel—kidney cancer	0.000231	0.000708	CcSEcCtD
Hydrocodone—Dermatitis—Paclitaxel—kidney cancer	0.000231	0.000708	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—kidney cancer	0.000229	0.000704	CcSEcCtD
Hydrocodone—Headache—Paclitaxel—kidney cancer	0.000229	0.000704	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—kidney cancer	0.000228	0.0007	CcSEcCtD
Hydrocodone—Hypersensitivity—Capecitabine—kidney cancer	0.000221	0.000679	CcSEcCtD
Hydrocodone—Nausea—Paclitaxel—kidney cancer	0.000217	0.000667	CcSEcCtD
Hydrocodone—Asthenia—Capecitabine—kidney cancer	0.000215	0.000661	CcSEcCtD
Hydrocodone—Pruritus—Capecitabine—kidney cancer	0.000212	0.000652	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—kidney cancer	0.000207	0.000635	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—kidney cancer	0.000206	0.000631	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—kidney cancer	0.000202	0.00062	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—kidney cancer	0.000202	0.00062	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—kidney cancer	0.000201	0.000618	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000201	0.000616	CcSEcCtD
Hydrocodone—Dizziness—Capecitabine—kidney cancer	0.000199	0.00061	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—kidney cancer	0.000198	0.000606	CcSEcCtD
Hydrocodone—Vomiting—Capecitabine—kidney cancer	0.000191	0.000586	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—kidney cancer	0.00019	0.000583	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—kidney cancer	0.00019	0.000582	CcSEcCtD
Hydrocodone—Rash—Capecitabine—kidney cancer	0.000189	0.000581	CcSEcCtD
Hydrocodone—Dermatitis—Capecitabine—kidney cancer	0.000189	0.000581	CcSEcCtD
Hydrocodone—Headache—Capecitabine—kidney cancer	0.000188	0.000577	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—kidney cancer	0.000188	0.000577	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000187	0.000574	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—kidney cancer	0.000181	0.000555	CcSEcCtD
Hydrocodone—Nausea—Capecitabine—kidney cancer	0.000178	0.000548	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000176	0.000541	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—kidney cancer	0.000175	0.000537	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—kidney cancer	0.000174	0.000534	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—kidney cancer	0.000173	0.00053	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—kidney cancer	0.000172	0.000528	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000167	0.000513	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—kidney cancer	0.000167	0.000512	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—kidney cancer	0.000166	0.000508	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000158	0.000486	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—kidney cancer	0.000153	0.00047	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—kidney cancer	0.000153	0.00047	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—kidney cancer	0.000143	0.000438	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—kidney cancer	0.000139	0.000426	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—kidney cancer	0.000137	0.00042	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—kidney cancer	0.000128	0.000393	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—kidney cancer	0.000123	0.000378	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—kidney cancer	0.000122	0.000375	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—kidney cancer	0.000122	0.000374	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—kidney cancer	0.000121	0.000372	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—kidney cancer	0.000115	0.000353	CcSEcCtD
